The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab (Q40531984)
Jump to navigation
Jump to search
scientific article published on July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab |
scientific article published on July 2004 |
Statements
1 reference
The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab (English)
1 reference
Anthony Rhodes
1 reference
Duncan Borthwick
1 reference
Rob Sykes
1 reference
Salam Al-Sam
1 reference
Angelo Paradiso
1 reference
1 July 2004
1 reference
1 reference
122
1 reference
1
1 reference
51-60
1 reference
Identifiers
1 reference
1 reference